The awards that researchers at the University of Basel receive for their scientific work, as well as their appointments to numerous institutions, are testimony to their outstanding commitment to science and society.
NanoZymeX is a biotech startup developing advanced enzyme-replacement therapies with proprietary lipid-based nanoparticles for rare genetic diseases. The company has secured CHF 150,000 in startup funding from Venture Kick.
Neurologist Prof. emeritus Dr. Ludwig Kappos has been awarded the 2026 John Dystel Prize for Multiple Sclerosis Research – one of the most prestigious honors in the field of multiple sclerosis research.
Dr. Alice R. Paine, a postdoctoral researcher in the Department of Environmental Sciences of the University of Basel, receives the 2026 President's Award from the Geological Society of London.
Prof. Dr. Marc Aurel Busche, professor of dementia at the University of Basel’s Department of Biomedicine, has been awarded the 2026 Rainwater Prize for Innovative Early Career Scientists.
University of Basel Neuroscientist Botond Roska, MD, PhD, will receive the Perl-UNC Neuroscience Prize for his pivotal discoveries in restoring sight to the blind.
GlioCART, a spin-off of the University of Basel, is developing a novel cell therapy targeting both glioblastoma tumors and their protective immunosuppressive microenvironment. The Venture Kick funding initiative is supporting this endeavour by providing CHF 150,000 in seed funding.
In 2025, eleven scientists from the University of Basel are recognized as some of the most frequently cited researchers in the world, according to the latest edition of the “Highly Cited Researchers” ranking.
The startup YQuantum aims to develop miniaturized hardware components for next-generation quantum computers. The company has now received CHF 150,000 in startup funding from the Venture Kick initiative.
The Multiple Sclerosis International Federation (MSIF) has awarded the Charcot Award 2025 to Professor Ludwig Kappos. The prize recognizes his lifelong achievements and outstanding research into the understanding and treatment of multiple sclerosis (MS).
Sign up for the Uni News Weekly newsletter and receive the weekly highlights directly in your inbox every Thursday.
